Back
Conduit Pharmaceuticals 10K Form
Sell
25
CDT
Conduit Pharmaceuticals
Last Price:
$2.42
Seasonality Move:
-43.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDT News And Ratings
See the #1 stock for the next 7 days that we like better than CDT
CDT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-4.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.24 |
| Price / Book: | 0.87 |
Profitability
| EPS (TTM): | -237.75000 |
|---|---|
| Net Income (TTM): | $-19.4M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Conduit Pharmaceuticals Earnings Forecast
Key Conduit Pharmaceuticals Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 0 years.
Conduit Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CDT |
| Website: | conduitpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CDT Technical Analysis vs Fundamental Analysis
Sell
25
Conduit Pharmaceuticals (CDT)
is a Sell
Is Conduit Pharmaceuticals a Buy or a Sell?
-
Conduit Pharmaceuticals stock is rated a SellThe current Conduit Pharmaceuticals [CDT] share price is $2.92. The Score for CDT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.